Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P).
about
Early and individualized goal-directed therapy for trauma-induced coagulopathyRecovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrateEffects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injuryFibrinogen concentrate improves survival during limited resuscitation of uncontrolled hemorrhagic shock in a Swine model.Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patientsClinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review.The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial.Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma-derived human FXIII concentrate in animalsTime course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.Pilot Randomized trial of Fibrinogen in Trauma Haemorrhage (PRooF-iTH): study protocol for a randomized controlled trialImpact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective studyTreatment and monitoring of coagulation abnormalities in children undergoing heart surgery.Fibrinogen replacement therapy: a critical review of the literature.Cryoprecipitate: an outmoded treatment?Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.Bleeding management for pediatric craniotomies and craniofacial surgery.Fibrinogen concentrate for bleeding--a systematic review.Practical management of major blood loss.Impact of Preemptive Fibrinogen Concentrate on Transfusion Requirements in Liver Transplantation: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.Management of Dilutional Coagulopathy during Pediatric Major Surgery.Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage.Differences in clotting parameters between species for preclinical large animal studies of cardiovascular devices.Fibrinogen concentrate in dilutional coagulopathy: a dose study in pigs.Severe pediatric blunt trauma--successful ROTEM-guided hemostatic therapy with fibrinogen concentrate and no administration of fresh frozen plasma or platelets.The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study.
P2860
Q26853422-12D3144A-E4AC-453E-9F94-6DA32D65A3E2Q33793633-84E3C8B1-BA16-40CE-AC71-4A559C17AED8Q33919203-EAB88ED2-B02F-4B68-A4E2-B14314ED5202Q33919248-9EBEBEB1-878A-4E02-86D0-C779537361F4Q34390320-8C1FE516-FEC9-4176-8F0C-9E7CFF666A67Q34485905-5B362D1C-7A95-4242-940B-97C1F0C89D75Q35908250-0E29FDBB-832F-4B55-ADF5-744F0AD7A4E8Q36209630-4B9DAE31-640F-4F95-A110-AA35514A9B71Q36719655-31A45073-F26C-43FC-9C72-CE0280909C07Q36854348-7F2B71F2-D44A-4BDE-AE83-2B4506411488Q37106075-34F9F000-8AAC-4037-8158-1CE81196F141Q37366934-C4213FBA-D806-4DEC-AD3F-398A86E0561AQ37813802-A01A49AD-62AE-48E5-AD06-6E84E8A8DF1AQ37966278-ACABAF7C-7DAE-4BD5-AE46-918EE0300B3CQ38044961-8B68A811-8324-488B-976A-335254FCE1EAQ38115586-03734275-BC23-44C7-A1A0-9EFA49E5925DQ38151867-979D65DB-C193-45B2-B456-1251BEF4183EQ38210761-A3C4CC21-B944-43B5-9F58-C116988853E1Q38233639-0975E280-B6FA-4187-ABE6-F598E3BBA586Q38273787-ADCBA155-77C3-4B94-9013-10CB5C9FB456Q39994821-608D15CE-C2B8-46CB-8693-E71750743C79Q41927430-BCFCC7F4-7700-4BB1-A813-D7407AC123C4Q44528586-CE738D61-A873-4FD2-B12D-3285081A544EQ46264283-81B41595-F1E0-430E-AC9A-DC008BD7F03FQ46639161-EE944CD2-F295-4C95-B963-C3C2C606A6E6Q46738555-12BE8764-76F0-47B6-B3D7-19983F5B9D19Q50503254-0DC7F79F-ED17-4860-9689-71D4718FD8BF
P2860
Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P).
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Animal model and clinical evid ...... ncentrate (Haemocomplettan P).
@ast
Animal model and clinical evid ...... ncentrate (Haemocomplettan P).
@en
type
label
Animal model and clinical evid ...... ncentrate (Haemocomplettan P).
@ast
Animal model and clinical evid ...... ncentrate (Haemocomplettan P).
@en
prefLabel
Animal model and clinical evid ...... ncentrate (Haemocomplettan P).
@ast
Animal model and clinical evid ...... ncentrate (Haemocomplettan P).
@en
P2093
P1476
Animal model and clinical evid ...... ncentrate (Haemocomplettan P).
@en
P2093
Christine Joch
Garrett E Bergman
Gerhard Dickneite
Ingo Pragst
P304
P356
10.1097/MBC.0B013E32832DA1C5
P577
2009-10-01T00:00:00Z